Ad
related to: journal of american medicine articles on coronavirus research and development
Search results
Results From The WOW.Com Content Network
Bebtelovimab is a neutralizing human immunoglobulin G1 (IgG1) monoclonal antibody, isolated from a patient who has recovered from the Coronavirus disease 2019 (COVID-19), directed against the spike (S) protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), that can potentially be used for immunization against COVID-19.
A universal coronavirus vaccine, also known as a pan-coronavirus vaccine, is a theoretical coronavirus vaccine that would be effective against all coronavirus strains. A universal vaccine would provide protection against coronavirus strains that have caused disease in humans, such as SARS-CoV-2 (including all its variants ), while also ...
In the United States, the Biomedical Advanced Research and Development Authority (BARDA), a federal agency funding disease-fighting technology, announced investments of nearly US$1 billion to support American COVID‑19 vaccine development and manufacture of the most promising candidates.
On 17 March 2020, Nature Medicine published a correspondence article titled "The proximal origin of SARS-CoV-2" that discussed the origin of the coronavirus that caused COVID-19 pandemic from genetic perspective. The article focused on analysing SARS-CoV-2's genome, and the sites that enable it to bind to human cells. [3]
PubMed Central (PMC) is a free digital repository that archives open access full-text scholarly articles that have been published in biomedical and life sciences journals. As one of the major research databases developed by the National Center for Biotechnology Information (NCBI), PubMed Central is more than a document repository.
The research related to this article drew criticism from other scientists due to fears that the SHC014-rMA15 chimeric virus could have pandemic potential. [13] This concern was renewed and echoed by members of the public during the COVID-19 pandemic . [ 14 ]
The Journal of the American Medical Association (JAMA), along with JAMA Network Open and eleven specialty journals, compose the JAMA Network family of journals. [1] The journals share a common website, [ 2 ] archives and other means of access (such as RSS feeds), [ 3 ] have common policies on publishing and public relations, [ 4 ] and pool ...
The final report, published October 15, 2012, is a review of more than 12,000 peer-reviewed publications, documents, transcripts and notes dating back to 1936 and interviews and follow up with 88 experts in influenza vaccine research, development, and use.